Literature DB >> 30659720

Successful treatment of porocarcinoma with maxacalcitol and imiquimod.

Tomoya Nagasawa1, Akiko Hirata2, Shiro Niiyama1, Yasunori Enomoto3, Hidetsugu Fukuda1.   

Abstract

This is the first report of a case of porocarcinoma that was successfully treated with maxacalcitol and imiquimod.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  contact immunotherapy; regression; vitamin D

Mesh:

Substances:

Year:  2019        PMID: 30659720     DOI: 10.1111/dth.12830

Source DB:  PubMed          Journal:  Dermatol Ther        ISSN: 1396-0296            Impact factor:   2.851


  3 in total

1.  [Management of malignant adnexal neoplasms of the skin].

Authors:  Pia Nagel; Verena Müller; Jochen Utikal
Journal:  Hautarzt       Date:  2021-06-17       Impact factor: 0.751

2.  Resolution of Metastatic Subungal Eccrine Porocarcinoma Treated with Intralesional Interleukin-2.

Authors:  Ashley Drohan; Jennifer Melvin; Joanne Murphy; Carman Giacomantonio; Lucy Helyer
Journal:  Curr Oncol       Date:  2020-12-30       Impact factor: 3.677

3.  Metastatic Porocarcinoma Effectively Managed by Pembrolizumab.

Authors:  Arminder Singh; Lam Nguyen; Stephanie Everest; Mikhail Vinogradov
Journal:  Cureus       Date:  2021-11-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.